Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

INTRODUCTION: Recurrence of atypical hemolytic uremic syndrome (aHUS) in renal allografts is common, leading to dialysis and graft failure. Pretransplant versus posttransplant initiation of eculizumab treatment in patients with aHUS has not been rigorously investigated. We hypothesized eculizumab pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Siedlecki, Andrew M., Isbel, Nicole, Vande Walle, Johan, James Eggleston, Jennifer, Cohen, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409407/
https://www.ncbi.nlm.nih.gov/pubmed/30899871
http://dx.doi.org/10.1016/j.ekir.2018.11.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409407/
https://www.ncbi.nlm.nih.gov/pubmed/30899871
http://dx.doi.org/10.1016/j.ekir.2018.11.010

Ejemplares similares